SEC, US Trustee Object To Releases In Amyris' Ch. 11 Plan
By Ben Zigterman · January 18, 2024, 6:57 PM EST
The U.S. Securities and Exchange Commission and the U.S. Trustee's Office have expressed new concerns about nonconsensual third-party releases in biotechnology company Amyris' Chapter 11 plan, arguing that such releases are...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login